We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

150 hedge funds and large institutions have $1.18B invested in Translate Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 21

27% more capital invested

Capital invested by funds: $936M → $1.18B (+$249M)

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

14% more funds holding

Funds holding: 132 → 150 (+18)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

80% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $10.7M

Holders
150
Holders Change
+18
Holders Change %
+13.64%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
39
Increased
51
Reduced
44
Closed
21
Calls
$2.1M
Puts
$10.7M
Net Calls
-$8.55M
Net Calls Change
-$5.73M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$34.5M
2
Macquarie Group
Macquarie Group
Australia
+$8.17M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$6.98M
4
Barclays
Barclays
United Kingdom
+$2.87M
5
BlackRock
BlackRock
New York
+$2.64M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$35.2M
2
AVA
Atlas Venture Advisors
Massachusetts
-$21.1M
3
Goldman Sachs
Goldman Sachs
New York
-$15M
4
RI
RTW Investments
New York
-$13.7M
5
GPP
Great Point Partners
Connecticut
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$4.3M +$2.87M +160,161 +219%
DCM
27
DAFNA Capital Management
California
$4.15M +$617K +34,463 +18%
Citadel Advisors
28
Citadel Advisors
Florida
$4.07M +$13.6K +759 +0.3%
Wells Fargo
29
Wells Fargo
California
$3.35M +$893K +49,890 +38%
Morgan Stanley
30
Morgan Stanley
New York
$3.13M +$623K +34,803 +26%
Allianz Asset Management
31
Allianz Asset Management
Germany
$2.89M +$128K +7,131 +5%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$2.79M -$51.9K -2,900 -2%
WP
33
Woodline Partners
California
$2.67M +$2.59M +144,843 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$2.65M +$831K +46,444 +48%
MCM
35
Marathon Capital Management
Maryland
$2.64M +$1.35M +75,200 +110%
Deutsche Bank
36
Deutsche Bank
Germany
$2.2M -$4.33M -242,098 -67%
HF
37
HRT Financial
New York
$2.19M +$2.13M +119,044 New
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$2.14M +$2.08M +116,189 New
Two Sigma Investments
39
Two Sigma Investments
New York
$2.08M -$2.47M -137,932 -55%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$2.01M +$62.6K +3,500 +3%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$1.9M – – –
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.86M +$132K +7,400 +8%
OIM
43
Oracle Investment Management
Connecticut
$1.84M +$1.79M +100,000 New
CS
44
Credit Suisse
Switzerland
$1.71M -$1.68M -93,593 -50%
First Trust Advisors
45
First Trust Advisors
Illinois
$1.53M +$1.49M +83,277 New
Point72 Asset Management
46
Point72 Asset Management
Connecticut
$1.49M +$1.45M +81,000 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.48M +$185K +10,311 +15%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.46M +$150K +8,400 +12%
Schroder Investment Management Group
49
Schroder Investment Management Group
United Kingdom
$1.33M +$1.3M +72,361 New
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$1.23M +$336K +18,800 +42%
1
2
3 4 5

TBIO Hedge Fund Activity: Q4 2020 in Review

150 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2020, worth a combined $1.18B — up 27% from $936M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TBIO positions and 21 closed out — a net gain of 18 holders — while 51 added to existing stakes and 44 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $34.5M. The largest seller was State Street, cutting an estimated $35.2M.

  • 150 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2020, up from 132 in Q3 2020.
  • Funds reported $1.18B of Translate Bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
  • 39 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2020 and 21 closed out, a net change of +18 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2020 was Invesco, an estimated $34.5M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2020 was State Street, an estimated $35.2M sold.

Based on aggregated 13F filings for Q4 2020.